Zinc Saves Kids, a global child‑health initiative of the International Zinc Association (IZA), has announced a new ...

Symposium brings together global leaders in immunogenicity to connect with China’s rapidly evolving pharmaceutical development landscapeSpeakers include thought leaders in biotherapeutics, complex ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the ...

MALMÖ, SE / ACCESS Newswire / January 21, 2026 / Ascelia Pharma AB (publ) (STO:ACE) today announced that Deputy CEO Julie Waras Brogren will leave the company to take up a CEO position in another ...

Up to $100 million in additional loan proceeds provide additional financial flexibility to advance detalimogene development ...

Sixth overall for Lantern’s A.I.-driven precision oncology pipelineOrphan designation expands LP-284's potential for an ...

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San ...

Agreement comes on the heels of Company inking an exclusive distribution agreement with Gulf Medical for Saudi ArabiaCreates ...

Davos: Investing in small scale farmers and rural entrepreneurs is a compelling business case and a geostrategic ...

Genentech will more than double the initial investment in a state-of-the-art biomanufacturing facility in Holly Springs to approximately $2 billion, bolstering Roche and Genentech’s $50 billion ...

Oral presentation to highlight first-ever clinical evidence supporting use of a targeted GYS1 substrate reduction therapy, ...

Conference Call and Webcast Scheduled for 1:30 p.m. PTALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), ...